Gliclazide - Diabetes Mellitus
You are here : Home > Formulary Search > Gliclazide - Diabetes Mellitus
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Preferred
Status 2
Green (see narrative)
Formulations :
- Modified release
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Immediate release tablets are preferred
Documentation
PAD Profile
ChemicalSubstance :
Gliclazide
Indication :
Diabetes Mellitus
Group Name :
Keywords :
sulphonylureas, Blood Glucose Lowering drug, Type II
Brand Names Include :
Diamicron, Zicron, Glydex, Edicil, Lamzarin, Exywin, Ziclaseg
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Gliclazide is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Diabetes Mellitus.
- Acarbose
- Alogliptin
- Alogliptin/metformin
- Biphasic Insulin Aspart - Novmix 30
- Biphasic Isophane Insulin - Humulin M3
- Biphasic Lispro Insulin - Humalog Mix 25
- Biphasic Lispro Insulin - Humalog Mix 50
- Canagliflozin/metformin
- Dapagliflozin
- Dapagliflozin/metformin
- Diazoxide
- Dulaglutide
- Empagliflozin
- Empagliflozin/metformin
- Ertugliflozin
- Exenatide
- Glibenclamide
- Glimepiride
- Glipizide
- Glucose
- Glyxambi (Linagliptin/empagliflozin)
- Insulin Aspart - Fiasp
- Insulin aspart - NovoRapid
- Insulin Aspart - Trurapi
- Insulin degludec
- Insulin degludec with liraglutide
- Insulin detemir
- Insulin glargine - Abasaglar
- Insulin glargine - Lantus
- Insulin glargine - Semglee
- Insulin Glargine - Toujeo
- Insulin glulisine - Apidra
- Insulin Lispro - Admelog
- Insulin Lispro - Humalog
- Insulin Lispro - Lyumjev
- Insulin pump - Type 1 diabetes
- Isophane (neutral insulin) - hypurin porcine 30/70
- Isophane Insulin - Humulin I
- Isophane Insulin - Hypurin Porcine Isophane
- Isophane Insulin - Insulatard
- Linagliptin
- Linagliptin/metformin
- Liraglutide
- Metformin hydrochloride
- Metformin hydrochloride/pioglitazone
- Metformin hydrochloride/sitagliptin
- Metformin hydrochloride/vildagliptin
- Pioglitazone hydrochloride
- Repaglinide
- Saxagliptin
- Saxagliptin/dapagliflozin
- Semaglutide
- Sitagliptin
- Soluble insulin - Hypurin porcine neutral
- Soluble insulin - Actrapid
- Soluble insulin - Humulin S
- Sotagliflozin
- Suliqua (Insulin glargine/lixisenatide)
- Tirzepatide
- Tolbutamide
- Vildagliptin
Committee Recommendations (1)
THE PREFERRED SULFONYLUREA:
Appropriate for initiation in primary care and/or continued in primary care following a recommendation from specialists in other health care sectors.
PRESCRIBE GENERICALLY - NOTE - the branded product, Diamicron, was considered BLACK at the PCN in May 2017.
Appropriate for initiation in primary care and/or continued in primary care following a recommendation from specialists in other health care sectors.
PRESCRIBE GENERICALLY - NOTE - the branded product, Diamicron, was considered BLACK at the PCN in May 2017.